What is the appropriate management of hyponatremia, including treatment thresholds based on serum sodium level and symptom severity?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 4, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Hyponatremia

Treatment of hyponatremia must be guided by symptom severity and acuity of onset, with severely symptomatic patients (seizures, coma, altered mental status) requiring immediate hypertonic saline to correct 5-6 mmol/L over 6 hours, while asymptomatic or mildly symptomatic patients should receive fluid restriction and treatment of the underlying cause.

Immediate Assessment and Risk Stratification

First, determine if this is true hyponatremia by checking serum osmolality. If serum osmolality is normal or high (>280 mOsm/L), consider pseudohyponatremia from hyperglycemia, hypertriglyceridemia, or laboratory error 1.

Next, assess volume status to categorize the hyponatremia:

  • Hypovolemic: Signs of dehydration, low urine sodium (<20 mEq/L), responds to volume expansion
  • Euvolemic: Normal volume status, inappropriately concentrated urine (>300 mOsm/kg), urine sodium >40 mEq/L—suggests SIADH
  • Hypervolemic: Ascites, edema, heart failure, cirrhosis 2

Determine symptom severity:

  • Severe symptoms: Seizures, coma, altered mental status, cardiorespiratory distress—indicates cerebral edema requiring immediate treatment 2
  • Mild symptoms: Nausea, vomiting, headache, confusion, weakness
  • Asymptomatic: No neurological symptoms

Establish acuity:

  • Acute: <48 hours duration—higher risk of cerebral edema, can tolerate faster correction
  • Chronic: >48 hours duration—risk of osmotic demyelination with rapid correction 2

Treatment Algorithm by Severity

Severely Symptomatic Hyponatremia (Seizures, Coma, Altered Mental Status)

This is a medical emergency requiring ICU-level care 2.

Immediate treatment with 3% hypertonic saline:

  • Administer 100-150 mL bolus of 3% saline over 10-20 minutes 3, 4
  • Goal: Increase serum sodium by 5-6 mmol/L within the first 6 hours or until severe symptoms resolve 2
  • Check serum sodium every 2 hours during active correction 2

Critical correction limits to prevent osmotic demyelination:

  • Maximum 8 mmol/L increase in first 24 hours 2
  • If you correct 6 mmol/L in the first 6 hours, you can only increase sodium by 2 mmol/L more in the remaining 18 hours 2
  • Maximum 18 mmol/L increase over 48 hours 5

Calculate sodium deficit:

  • Sodium deficit = Desired increase in Na (mmol/L) × (0.5 × ideal body weight in kg) 2
  • Use this conservatively to guide 3% saline requirements

Once severe symptoms resolve:

  • Transition to mild symptom or asymptomatic protocol
  • Stop hypertonic saline and switch to slower correction strategies 2

Mildly Symptomatic Hyponatremia (Nausea, Headache, Confusion)

Sodium <120 mmol/L with mild symptoms:

  • Transfer to intermediate care unit for monitoring 2
  • Check serum sodium every 4 hours 2
  • Fluid restriction to 1 L/day 2
  • Consider oral sodium chloride 100 mEq TID if no response 2
  • Monitor daily weights and strict intake/output 2

Sodium 120-125 mmol/L:

  • Fluid restriction 1-1.5 L/day 6, 1
  • Stop or reduce diuretics 6, 7, 1
  • Monitor electrolytes daily
  • Correct hypokalemia, especially if hepatic encephalopathy present 1

Asymptomatic Hyponatremia

Sodium 126-135 mmol/L with normal creatinine:

  • Continue diuretics if needed, but monitor closely 7
  • No water restriction necessary 7
  • Observe serum electrolytes

Sodium 121-125 mmol/L:

  • Stop diuretics (international opinion differs, but this is the safer approach) 7
  • Fluid restriction 1-1.5 L/day 1
  • If creatinine elevated (>150 mmol/L or rising), provide volume expansion with normal saline or colloid 7

Sodium <120 mmol/L:

  • Stop diuretics immediately 7
  • Most patients should receive volume expansion with colloid or saline 7
  • Avoid increasing sodium >12 mmol/L per 24 hours 7

Etiology-Specific Management

SIADH (Euvolemic Hyponatremia)

First-line treatment:

  • Fluid restriction <1 L/day is the cornerstone 2
  • High protein diet 2
  • Oral sodium chloride supplementation if needed 2

Second-line options when fluid restriction fails:

  • Oral urea 40g in 100-150 mL normal saline every 8 hours—very effective and safe 2, 8
  • Vaptans (tolvaptan, satavaptan) improve sodium in 45-82% of cases but reserved for short-term use due to hepatotoxicity risk 9, 3
  • Loop diuretics with sodium supplementation (requires potassium monitoring) 2

Cerebral Salt Wasting (Hypovolemic)

Treatment based on symptoms:

  • Severe symptoms: ICU admission, 3% hypertonic saline + fludrocortisone for 7 days 2
  • Mild symptoms: Normal saline infusion, oral sodium supplementation, fludrocortisone 2
  • Critical warning: Fluid restriction in cerebral salt wasting (especially post-SAH) causes cerebral infarction in 81% of cases 2

Cirrhosis with Hypervolemic Hyponatremia

Outpatient management (asymptomatic, sodium >120 mmol/L):

  • Sodium restriction (no added salt, <5-6.5 g/day) 6
  • Fluid restriction 1-1.5 L/day 6, 1
  • Reduce or stop diuretics 6, 1
  • Adjust lactulose to avoid excessive stooling 1

Inpatient management (symptomatic or sodium <120 mmol/L):

  • Discontinue diuretics and laxatives 1
  • Evaluate for infection (diagnostic paracentesis) 1
  • Albumin infusion to improve renal perfusion 9, 1
  • Midodrine for vasoconstriction in hypotension 6, 1
  • Hold non-selective beta-blockers if systolic BP <90 mmHg 1

Life-threatening cases or pre-transplant:

  • Cautious 3% hypertonic saline with slow correction 9, 1
  • Vaptans only for short-term use in severe cases awaiting transplant 9, 1
  • Hemodialysis for severe kidney injury 1

Critical Pitfalls to Avoid

Overcorrection causing osmotic demyelination syndrome:

  • Risk groups: chronic hyponatremia, alcoholism, malnutrition, liver disease, hypokalemia 2
  • Never exceed 8 mmol/L in 24 hours 2
  • Monitor for water diuresis—can cause rapid overcorrection 10, 4
  • If overcorrection occurs: Give desmopressin and/or 5% dextrose to re-lower sodium 10, 4

Fluid restriction in wrong context:

  • Never restrict fluids in hypovolemic hyponatremia—this worsens outcomes 2
  • In cerebral salt wasting post-SAH, fluid restriction causes cerebral infarction 2

Hypovolemic hyponatremia from diuretics:

  • Common in cirrhosis patients 11
  • Requires stopping diuretics and volume expansion with normal saline, not fluid restriction 6, 7

Inadequate monitoring:

  • During active correction with hypertonic saline: check sodium every 2 hours 2
  • Monitor urine output, urine sodium, and osmolality to detect water diuresis 10, 4

Treating the number instead of the patient:

  • Asymptomatic mild hyponatremia (126-135 mmol/L) often requires only observation and treatment of underlying cause 7
  • Severity of symptoms matters more than absolute sodium level for determining treatment urgency 2

References

Research

The treatment of acute symptomatic hyponatraemia in the hospital setting.

Best practice & research. Clinical endocrinology & metabolism, 2026

Research

Hyponatraemia-treatment standard 2024.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2024

Research

Overcorrection of Hyponatremia: A Complicated Story.

Electrolyte & blood pressure : E & BP, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.